Waters P - Search Results

1

Clinical presentation and prognosis in MOG-antibody disease: a UK study.

Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J. Jurynczyk M, et al. Among authors: waters p. Brain. 2017 Dec 1;140(12):3128-3138. doi: 10.1093/brain/awx276. Brain. 2017. PMID: 29136091

2

Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.

Vincent A, Waters P, Leite MI, Jacobson L, Koneczny I, Cossins J, Beeson D. Vincent A, et al. Among authors: waters p. Ann N Y Acad Sci. 2012 Dec;1274:92-8. doi: 10.1111/j.1749-6632.2012.06789.x. Ann N Y Acad Sci. 2012. PMID: 23252902

3

The search for new antigenic targets in myasthenia gravis.

Cossins J, Belaya K, Zoltowska K, Koneczny I, Maxwell S, Jacobson L, Leite MI, Waters P, Vincent A, Beeson D. Cossins J, et al. Among authors: waters p. Ann N Y Acad Sci. 2012 Dec;1275:123-8. doi: 10.1111/j.1749-6632.2012.06833.x. Ann N Y Acad Sci. 2012. PMID: 23278587 Review.

4

Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies.

Damásio J, Leite MI, Coutinho E, Waters P, Woodhall M, Santos MA, Carrilho I, Vincent A. Damásio J, et al. Among authors: waters p. JAMA Neurol. 2013 Apr;70(4):498-501. doi: 10.1001/jamaneurol.2013.1872. JAMA Neurol. 2013. PMID: 23380884

5

Progressive encephalomyelitis with rigidity and myoclonus: a syndrome with diverse clinical features and antibody responses.

Shugaiv E, Leite MI, Şehitoğlu E, Woodhall M, Çavuş F, Waters P, İçöz S, Birişik Ö, Uğurel E, Ulusoy C, Kürtüncü M, Vural B, Vincent A, Akman-Demir G, Tüzün E. Shugaiv E, et al. Among authors: waters p. Eur Neurol. 2013;69(5):257-62. doi: 10.1159/000342237. Epub 2013 Feb 20. Eur Neurol. 2013. PMID: 23429048

6

Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy.

Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ, Vincent A, Lang B. Brenner T, et al. Among authors: waters p. Epilepsia. 2013 Jun;54(6):1028-35. doi: 10.1111/epi.12127. Epub 2013 Mar 6. Epilepsia. 2013. PMID: 23464826 Free article.

7

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.

Kitley J, Elsone L, George J, Waters P, Woodhall M, Vincent A, Jacob A, Leite MI, Palace J. Kitley J, et al. Among authors: waters p. J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):918-21. doi: 10.1136/jnnp-2012-304774. Epub 2013 Mar 6. J Neurol Neurosurg Psychiatry. 2013. PMID: 23467418

8

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.

Min JH, Waters P, Vincent A, Kang ES, Lee S, Lee DK, Lee KH, Kim BJ. Min JH, et al. Among authors: waters p. J Clin Neurosci. 2013 Jul;20(7):938-42. doi: 10.1016/j.jocn.2012.08.007. Epub 2013 May 11. J Clin Neurosci. 2013. PMID: 23673142

9

Neuromyelitis optica IgG causes placental inflammation and fetal death.

Saadoun S, Waters P, Leite MI, Bennett JL, Vincent A, Papadopoulos MC. Saadoun S, et al. Among authors: waters p. J Immunol. 2013 Sep 15;191(6):2999-3005. doi: 10.4049/jimmunol.1301483. Epub 2013 Aug 9. J Immunol. 2013. PMID: 23935196 Free PMC article.

10

Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.

Kitley J, Leite MI, Küker W, Quaghebeur G, George J, Waters P, Woodhall M, Vincent A, Palace J. Kitley J, et al. Among authors: waters p. JAMA Neurol. 2013 Nov;70(11):1375-81. doi: 10.1001/jamaneurol.2013.3890. JAMA Neurol. 2013. PMID: 23999580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

746 results

Search Page